Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ensitrelvir (S-217622) fumarate is a novel orally active inhibitor, targeting the SARS-CoV-2 3CL protease (IC50 = 13 nM). It demonstrates non-covalent and non-peptidic characteristics. This compound represents a pioneering advancement in the development of effective antiviral agents against the SARS-CoV-2 virus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 53.00 |
Description | Ensitrelvir (S-217622) fumarate is a novel orally active inhibitor, targeting the SARS-CoV-2 3CL protease (IC50 = 13 nM). It demonstrates non-covalent and non-peptidic characteristics. This compound represents a pioneering advancement in the development of effective antiviral agents against the SARS-CoV-2 virus. |
In vitro | In a cytopathic effect (cpe)-inhibition assay conducted on VeroE6/TMPRSS2 cells infected with SARS-CoV-2, Ensitrelvir fumarate demonstrated EC50 values around 0.4 μM for not only the wild-type virus but also the Alpha, Beta, Gamma, and Delta variants. For SARS-CoV and MERS-CoV, the EC50 values were found to be 0.21 μM and 1.4 μM, respectively[1]. |
In vivo | Ensitrelvir fumarate effectively reduces SARS-CoV-2 replication within the lungs of mice in a dose-dependent manner[2]. |
Synonyms | S-217622 fumarate |
Molecular Weight | 647.96 |
Formula | C26H21ClF3N9O6 |
CAS No. | 2757470-18-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ensitrelvir fumarate 2757470-18-9 S-217622 fumarate Ensitrelvir Fumarate S 217622 Fumarate S217622 Fumarate S-217622 Fumarate inhibitor inhibit